NDC 69488-010

PLUVICTO

Lutetium Lu 177 Vipivotide Tetraxetan

PLUVICTO is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Advanced Accelerator Applications Usa, Inc. The primary component is Lutetium Lu-177 Vipivotide Tetraxetan.

Product ID69488-010_778126c6-8402-4888-bec9-24ed4eba816f
NDC69488-010
Product TypeHuman Prescription Drug
Proprietary NamePLUVICTO
Generic NameLutetium Lu 177 Vipivotide Tetraxetan
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2022-03-23
Marketing CategoryNDA /
Application NumberNDA215833
Labeler NameAdvanced Accelerator Applications USA, Inc
Substance NameLUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
Active Ingredient Strength27 mCi/mL
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 69488-010-61

1 VIAL, GLASS in 1 PACKAGE (69488-010-61) > 7.5 mL in 1 VIAL, GLASS
Marketing Start Date2022-03-23
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [PLUVICTO]

Mark Image

Registration | Serial
Company
Trademark
Application Date
PLUVICTO
PLUVICTO
88758613 not registered Live/Pending
ENDOCYTE, INC.
2020-01-14
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.